Ignite Creation Date:
2024-05-06 @ 2:51 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02145143
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2014-05-20
Brief Title:
Enhancing Radioiodine RAI Incorporation Into BRAF Mutant RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib A Pilot Study
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center